M. Bradburn, J. Deeks, J. Berlin, and A. Localio. Statistics in medicine, 26 (1):
53-77(January 2007)6691<m:linebreak></m:linebreak>LR: 20071115; GR: U18 HS10399/HS/AHRQ HHS/United States; JID: 8215016; 0 (Pharmaceutical Preparations); ppublish;<m:linebreak></m:linebreak>Metaanàlisi.
Y. Chen, C. Hu, and Y. Wang. Biostatistics (Oxford, England), 7 (4):
515-29(October 2006)5077<m:linebreak></m:linebreak>JID: 100897327; 2006/02/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
Y. Chi, and C. Chen. Statistics in medicine, 27 (29):
6175-89(December 2008)5263<m:linebreak></m:linebreak>LR: 20090730; JID: 8215016; 0 (Antineoplastic Agents); 33419-42-0 (Etoposide); ppublish;<m:linebreak></m:linebreak>Fase II.
N. Dendukuri, E. Rahme, P. Bélisle, and L. Joseph. Biometrics, 60 (2):
388-97(June 2004)5555<m:linebreak></m:linebreak>JID: 0370625; ppublish;<m:linebreak></m:linebreak>Proves diagnòstiques; Sample size.
S. Geneletti, S. Richardson, and N. Best. Biostatistics (Oxford, England), 10 (1):
17-31(January 2009)4716<m:linebreak></m:linebreak>GR: Department of Health/United Kingdom; JID: 100897327; 2008/05/14 aheadofprint; ppublish;.
B. Giraudeau, and J. Mary. Statistics in medicine, 20 (21):
3205-14(November 2001)5343<m:linebreak></m:linebreak>LR: 20071115; CI: Copyright 2001; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Sample size; Mesures de concordància.